Fund HoldingsCaligan Partners LP

Total Portfolio Value
$428.00M
Total Bought
$63.89M
Total Sold
$2.52M
Net Transaction
+$61.37M
Filing Period:
Securities
SharesValue ($K)
Q1 2024
Q2 2024
Change
Q1 2024
Q2 2024
Weight (%)
Change
ALIMERA SCIENCES INC16,835,15416,835,154065,65793,60321.87%+27,946
BIOCRYST PHARMACEUTICALS INC(BCRX)758,5024,598,737+3,840,2353,85328,4206.64%+24,567
MINERALYS THERAPEUTICS INC(MLYS)0745,758+745,75808,7252.04%+8,725
EXELIXIS INC(EXEL)1,100,7301,525,730+425,00026,12034,2838.01%+8,163
AGIOS PHARMACEUTICALS INC(AGIO)484,711514,711+30,00014,17322,1945.19%+8,021
VERONA PHARMA PLC1,296,4471,843,756+547,30920,86026,6616.23%+5,801
I MAB756,5383,374,791+2,618,2531,4075,6361.32%+4,229
ANIKA THERAPEUTICS INC1,435,9931,435,993036,47436,3748.50%-101
ENANTA PHARMACEUTICALS INC858,0701,042,889+184,81914,98213,5263.16%-1,456
OUTLOOK THERAPEUTICS INC500,000500,00005,9703,6900.86%-2,280
Y-MABS THERAPEUTICS INC587,276582,078-5,1989,5497,0321.64%-2,518
EVOLUS INC1,888,8812,167,790+278,90926,44423,5215.50%-2,924
LIQUIDIA CORPORATION(LQDA)10,360,94510,360,9450152,824124,33129.05%-28,493
Page 1 of 1